• Webinar
    #Biotech ASX:PTX

    Prescient Therapeutics Investor Briefing

    CEO and Managing Director Steven Yatomi-Clarke to discuss the $6.5 million Share Purchase Plan (SPP) that is underway and other business activities.
    August 4
    6 months ago
    Watch
    • 178 < Discover more events
    Interested in the ASX listed companies in this event? Check out the latest news, announcements, financial data, and capital raise history for: